clopidogrel has been researched along with Myeloproliferative Disorders in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chai, CN; Chiu, L; Ding, CSL; Gallardo, CA; Lee, J; Ong, KH; Poon, KS; Tan, K; Villanueva, A; Yan, B; Yong, KJ; Zhou, J | 1 |
| Neubauer, M; Robier, C; Stettin, M | 1 |
| Eikelboom, J | 1 |
| Gemmell, R; Hartwell, T; Manoharan, A | 1 |
1 review(s) available for clopidogrel and Myeloproliferative Disorders
| Article | Year |
|---|---|
Aspirin resistance: does it exist and is it an important clinical problem?
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Blood Platelets; Cardiovascular Diseases; Clopidogrel; Cyclooxygenase 1; Cyclooxygenase Inhibitors; Drug Resistance; Humans; Myeloproliferative Disorders; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Thrombosis; Ticlopidine | 2006 |
3 other study(ies) available for clopidogrel and Myeloproliferative Disorders
| Article | Year |
|---|---|
A novel JAK2 R564* variant in a patient with thrombocytosis.
Topics: Clopidogrel; Female; Humans; Janus Kinase 2; Middle Aged; Mutation; Myeloproliferative Disorders; Platelet Aggregation Inhibitors; Thrombocytosis | 2020 |
Changes in response to antiaggregatory treatment in patients with myeloproliferative neoplasms: a sequential study using multiple electrode aggregometry.
Topics: Adenosine Diphosphate; Adult; Aged; Arachidonic Acid; Aspirin; Blood Platelets; Case-Control Studies; Clopidogrel; Electrodes; Female; Hematologic Neoplasms; Humans; Male; Middle Aged; Myeloproliferative Disorders; Platelet Aggregation; Platelet Aggregation Inhibitors; Receptors, Thrombin; Thrombosis; Ticlopidine; Treatment Outcome | 2013 |
Use of whole blood platelet lumi-aggregometry to optimize anti-platelet therapy in patients with chronic myeloproliferative disorders.
Topics: Aspirin; Chronic Disease; Clopidogrel; Dietary Supplements; Dose-Response Relationship, Drug; Garlic; Humans; Luminescent Measurements; Myeloproliferative Disorders; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Ticlopidine | 2006 |